DEVV

Bioscience Neutraceuticals (CE) (DEVV)

Bioscience Neutraceuticals Inc (CE)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:DEVV

1 2 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2022/08/23	23 : 32	Edgar (US Regulatory)	Revocation of Exchange Act Registration Pursuant to Section 12(j) (revoked)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2020/03/31	01 : 34	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2019/11/13	05 : 52	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2019/08/13	02 : 15	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2019/05/16	04 : 47	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2019/04/23	00 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2019/04/10	02 : 21	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2019/04/01	23 : 48	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2019/02/08	02 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2019/01/19	01 : 17	Edgar (US Regulatory)	Information Statement - All Other (definitive) (def 14c)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2019/01/09	20 : 21	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2019/01/04	03 : 14	Edgar (US Regulatory)	Proxy Statement - Other Information (preliminary) (pre 14c)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2018/12/12	20 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2018/11/20	07 : 49	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2018/11/15	07 : 20	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2018/11/09	06 : 32	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2018/05/15	01 : 11	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2018/04/13	05 : 30	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2018/04/04	02 : 27	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2017/12/08	07 : 00	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2017/12/06	06 : 22	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2017/11/10	05 : 56	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2017/10/12	03 : 41	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2017/05/23	01 : 28	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2017/05/18	04 : 42	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2017/05/16	00 : 52	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2017/05/15	23 : 51	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2017/05/02	02 : 13	Edgar (US Regulatory)	Statement Regarding Change in Majority of Directors Pursuant to Rule 14f-1 (sc 14f1)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2017/03/31	20 : 43	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)
2016/11/11	00 : 58	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:DEVV	Bioscience Neutraceuticals Inc (CE)